Clinical Trials Logo
  1. Home
  2. Major Depressive Disorder
  3. NCT06293781
  4. Details
NCT06293781 Clinical Trial

Application of the Web-based Acceptance and Commitment Therapy for Depression

Major Depressive Disorder Clinical Trial

— ACTION  

Official title:
The Efficacy and Treatment Mechanisms of the Web-based Acceptance and Commitment Therapy for Patients With Major Depressive Disorder

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT06293781
Other study ID # GachonU
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date December 19, 2022
Est. completion date February 28, 2025

Study information
Verified date February 2024
Source Gachon University
Contact Kyoung-Sae Na, MD, PhD
Phone 82324689932
Email ksna13@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

PROSPECTIVE INTERVENTION STUDY; EFFICACY OF WEB-BASED ACCEPTANCE AND COMMITMENT THERAPY

Description:

Acceptance Commitment Therapy (ACT) is known to help people recover from depression by improving psychological flexibility through acceptance, defusion, self-as-context, present moment, committed action, and helping them live a values-based life. This study is a randomized controlled trial to determine if web-based ACT leads to changes in the psychological flexibility and cognitive fusion. Also, through the functional MRI study, possible treatment mechanisms by which the web-based ACT exerts will be identified.

Recruitment information / eligibility
Status Recruiting
Enrollment 50
Est. completion date February 28, 2025
Est. primary completion date February 28, 2025
Accepts healthy volunteers No
Gender All
Age group 19 Years to 65 Years
Eligibility Inclusion Criteria: - Patients who diagnosed major depressive disorder Exclusion Criteria: - Patients who have serious medical problems, metal implants in their bodies, severe brain injury or brain disease - Women who were pregnant or nursing - Patients at high risk for suicide

Study Design

Related Conditions & MeSH terms

Intervention

Device:
• Web-based ACT
ACT program delivered online
Behavioral:
• Treatment as usual
Treatment as usual for major depressive disorder

Locations
Country Name City State
Korea, Republic of Kyoung-Sae Na Incheon Please Incheon

Sponsors (1)
Lead Sponsor Collaborator
Gachon University

Country where clinical trial is conducted

Korea, Republic of, 

Outcome
Type Measure Description Time frame Safety issue
Primary Acceptance and Action Questionnaire-II Psychological flexibility 6 weeks
Secondary Cognitive Fusion Questionnaire Cognitive fusion 6 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT05537558 - Precision Medicine for the Prediction of Treatment (PROMPT) Response (PROMPT)
Terminated NCT02192099 - Open Label Extension for GLYX13-C-202, NCT01684163 Phase 2
Completed NCT03142919 - Lipopolysaccharide (LPS) Challenge in Depression Phase 2
Recruiting NCT05547035 - Identification of Physiological Data by a Wearable Monitor in Subjects Suffering From Major Depression Disorders N/A
Terminated NCT02940769 - Neurobiological Effects of Light on MDD N/A
Recruiting NCT05892744 - Establishing Multimodal Brain Biomarkers for Treatment Selection in Depression Phase 4
Recruiting NCT05537584 - SMART Trial to Predict Anhedonia Response to Antidepressant Treatment Phase 4
Active, not recruiting NCT05061706 - Multicenter Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder Phase 3
Completed NCT04479852 - A Study of the Safety and Efficacy of SP-624 in the Treatment of Adults With Major Depressive Disorder Phase 2
Recruiting NCT04032301 - Repeated Ketamine Infusions for Comorbid PTSD and MDD in Veterans Phase 1
Recruiting NCT05527951 - Enhanced Measurement-Based Care Effectiveness for Depression (EMBED) Study N/A
Completed NCT03511599 - Cycloserine rTMS Plasticity Augmentation in Depression Phase 1
Recruiting NCT04392947 - Treatment of Major Depressive Disorder With Bilateral Theta Burst Stimulation N/A
Recruiting NCT05895747 - 5-HTP and Creatine for Depression R33 Phase Phase 2
Recruiting NCT05273996 - Predictors of Cognitive Outcomes in Geriatric Depression Phase 4
Recruiting NCT05813093 - Interleaved TMS-fMRI in Ultra-treatment Resistant Depression N/A
Recruiting NCT05135897 - The Neurobiological Fundaments of Depression and Its Relief Through Neurostimulation Treatments
Enrolling by invitation NCT04509102 - Psychostimulant Augmentation of Repetitive TMS for the Treatment of Major Depressive Disorder Early Phase 1
Recruiting NCT06026917 - Assessing Dopamine Transporter Occupancy in the Patients With Depression Brain With Toludesvenlafaxine Hydrochloride Extended-Release Tablets Using 11C-CFT Positron Emission Tomography (PET) Phase 4
Recruiting NCT06145594 - EMA-Guided Maintenance TMS for Depression N/A